NASDAQ · Diagnostics & Research

Illumina Inc (ILMN)

$235.99 -18.64%

39 In band Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$166.97+41.34%

Company profile

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

SectorHealthcare

IndustryDiagnostics & Research

Market cap$41.78B

P/E ratio51.62

EPS$5.36

Beta1.416

Dividend yield0.00%

52-week high$309.35

52-week low$90.10

Similar stocks in Diagnostics & Research

TMO Thermo Fisher Scientific Inc RSI 59 MTD Mettler-Toledo International Inc RSI 65 CSTL Castle Biosciences Inc RSI 61 FONR Fonar Corp RSI 75 NTRA Natera Inc RSI 57 CRL Charles River Laboratories International Inc RSI 68 WGS GeneDx Holdings Corp - Class A RSI 49 BDSX Biodesix Inc RSI 44

30 days of PRO Unlimited free, no card

RSI alerts for ILMN

An email when ILMN closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 8:48 PM EDT